Related Experiment Videos

Remnant-like particle cholesterol may indicate atherogenic risk in patients on chronic hemodialysis

H Oda1, N Yorioka, S Okushin

  • 1Second Department of Internal Medicine, Hiroshima University School of Medicine, Japan.

Nephron
|January 1, 1997
PubMed

Insights

Remnant-like particle cholesterol (RLP-C) is elevated in hemodialysis patients compared to controls. Higher RLP-C levels correlate with increased atherogenic risk factors, suggesting its potential as an indicator in this population.

Area of Science:

  • Cardiovascular Research
  • Nephrology
  • Clinical Biochemistry

Background:

  • Atherosclerosis is a growing concern in hemodialysis (HD) patients.
  • The role of remnant-like particle cholesterol (RLP-C) in atherosclerosis is recognized, but not well-studied in HD populations.

Purpose of the Study:

  • To investigate the relationship between RLP-C levels and various lipid parameters, oxidative stress markers, and apolipoproteins in HD patients.
  • To assess the correlation of RLP-C with atherogenic indices in HD patients.

Main Methods:

  • Serum RLP-C levels were measured in HD patients and normal controls.
  • Lipid profiles (TC, TG, LDL-C, HDL-C), malondialdehyde (MDA), apolipoproteins (ApoA-I, ApoB), and lipoprotein fractions (VLDL, IDL, LDL, HDL) were analyzed.
  • Correlations between RLP-C and clinical/biochemical parameters, including atherogenic indices, were examined.

Main Results:

  • HD patients exhibited significantly higher RLP-C levels than controls (8.2 vs. 2.7 mg/dl).
  • RLP-C positively correlated with total cholesterol, triglycerides, LDL-C, MDA, ApoB, VLDL(%), and IDL(%), and negatively with HDL-C.
  • RLP-C showed positive correlations with atherogenic indices [(TC-HDL-C)/HDL-C and (VLDL+LDL)/HDL] and a negative correlation with ApoA-I/ApoB.

Conclusions:

  • RLP-C is significantly elevated in hemodialysis patients.
  • RLP-C levels are closely associated with atherogenic lipid profiles and oxidative stress markers.
  • RLP-C may serve as a valuable indicator of atherogenic risk in patients undergoing hemodialysis.

Related Concept Videos